High Tide and NuLeaf Naturals Join U.S. National Compassionate Care Council as Founding Members
MWN-AI** Summary
High Tide Inc. and its subsidiary, NuLeaf Naturals, have announced their participation as founding members of the U.S. National Compassionate Care Council (NCCC). This strategic move aligns with High Tide’s commitment to promoting responsible cannabinoid-based wellness products as the landscape of federal cannabis policy in the United States undergoes significant change. High Tide’s CEO, Raj Grover, emphasized the company's goal to leverage its expertise in health-focused brands like NuLeaf Naturals and FAB CBD to influence both federal and state cannabis policies, enhancing patient access to cannabinoid therapies.
The NCCC aims to improve patient access to cannabinoid-based treatments by modernizing healthcare standards and advancing evidence-based policies. The Council comprises healthcare-focused organizations from the medicinal cannabis sector that prioritize product quality and optimal patient outcomes. Alongside High Tide and NuLeaf Naturals, other founding members include notable companies such as Feals, Medterra CBD LLC, and Tilray Inc.
Recent federal initiatives to reschedule cannabis and consider Medicare reimbursement for hemp-derived products signal a potential paradigm shift in U.S. healthcare that could significantly benefit High Tide’s U.S. operations. By engaging with the NCCC, the company seeks to contribute expertise that supports broader efforts for expanding patient access to effective cannabinoid therapies.
Founded in 2014, NuLeaf Naturals is recognized for producing high-quality cannabinoid products and has received acclaim for its commitment to safety and efficacy. High Tide continues to expand its impact as a leader in the cannabis industry through its diversified operations and retail strategies. This collaboration with the NCCC underscores High Tide's dedication to improving both patient access and the overall landscape of cannabinoid therapies in the United States.
MWN-AI** Analysis
High Tide Inc. (HITI) and its subsidiary NuLeaf Naturals have made a strategic decision to join the U.S. National Compassionate Care Council (NCCC) as founding members. This move comes at a pivotal time as the landscape for cannabis regulations in the U.S. appears to be evolving, particularly with increasing discussions around federal rescheduling of cannabis and potential Medicare reimbursement for hemp-derived products.
For investors, this association signals High Tide's commitment to influencing policy that could enhance access to cannabinoid therapies. As the NCCC focuses on modernizing healthcare standards and advancing evidence-based policies, this partnership may provide High Tide significant leverage in shaping favorable regulations, enhancing its market position. Given High Tide's established market share in Canada and its ambitious expansion in the U.S., involvement with the NCCC could catalyze further growth.
Investors should monitor the ongoing regulatory developments closely. Legislation favoring cannabis could open up new markets or increase the existing market potential for companies like High Tide and NuLeaf Naturals, positioning them favorably against competitors. The upcoming federal policies could enhance product demand, potentially boosting revenue streams for its hemp-derived CBD products.
Moreover, High Tide's robust infrastructure, including its vast retail network through Canna Cabana and its commitment to research-driven product development, may allow it to capture significant market share as consumer preferences shift towards quality and safety in cannabinoid products.
In summary, High Tide's participation in the NCCC is a bullish indicator for investors. However, with regulatory shifts still an uncertainty, it is prudent for investors to stay informed and assess how these changes could impact the portfolio. Diversifying investments within the sector could be advisable to mitigate risks, given the dynamic nature of cannabis legislation.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
CALGARY, AB, March 4, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, and its leading U.S. hemp-derived CBD subsidiary, NuLeaf Naturals, today announced they have joined the National Compassionate Care Council (NCCC) as founding members.
"Federal cannabis policy in the United States is entering a meaningful transition," said Raj Grover, Founder and Chief Executive Officer of High Tide. "Through our experience building health-focused brands such as NuLeaf Naturals and FAB CBD, we have developed meaningful expertise in serving consumers seeking cannabinoid-based wellness products within a responsible regulatory framework. We are pleased to join the NCCC so that High Tide and NuLeaf can help contribute to the development of thoughtful U.S. federal and state medical cannabis policy, while supporting efforts aimed at improving patient access to cannabinoid therapies across the United States," added Mr. Grover.
The NCCC is dedicated to improving patient access to cannabinoid therapies by modernizing healthcare standards and advancing evidence-based policy. The Council brings together healthcare-focused organizations across the medicinal cannabis sector that prioritize product quality, research, and patient outcomes.
In addition to High Tide and its subsidiaries NuLeaf Naturals and FAB CBD, founding members include Feals, Medterra CBD LLC, Tilray Inc., Realm of Caring, Lazarus Naturals, Constance CBD, and Equilibria.
Recent federal initiatives to reschedule cannabis and explore Medicare reimbursement for hemp-derived cannabinoid products signal a potential shift in U.S. healthcare policy that can have a material impact for High Tide's U.S. based hemp-derived CBD subsidiaries. Through its participation in the NCCC, High Tide aims to contribute industry expertise while supporting broader efforts to expand patient access to safe and effective cannabinoid therapies.
ABOUT HIGH TIDE
High Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:
Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 219 domestic locations. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products.
Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.
High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
ABOUT NULEAF NATURALS
Founded in 2014 in Denver, Colorado, NuLeaf Naturals is one of America's leading cannabinoid companies. Since its inception, the company has been committed to creating the world's highest-quality cannabinoid products in their purest and most potent form. Most of NuLeaf's products are produced at its cGMP-certified facility, enabling it to manufacture ground-breaking cannabinoid formulations while exceeding the highest levels of regulatory compliance. Their cannabinoid products are sold direct-to-consumer from their website and are also available at select bricks-and-mortar stores across the U.S. The company is committed to creating safe, consistent, and effective products and has proudly received over 35,000 verified 5-star customer reviews through its e-commerce platform.
CONTACT INFORMATION
Media Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee@hightideinc.com
403-770-3080
Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: future shifts in U.S. policy, impact on the Corporation's subsidiaries, and outcomes of the coalition. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
SOURCE High Tide Inc.
FAQ**
How will High Tide Inc. HITI leverage its membership in the National Compassionate Care Council to influence U.S. federal and state medical cannabis policy, especially for its hemp-derived subsidiary, NuLeaf Naturals?
What specific strategies does High Tide Inc. HITI plan to implement through its founding membership in the NCCC to enhance patient access to cannabinoid therapies across the United States?
Can High Tide Inc. HITI provide insights into how recent federal initiatives regarding cannabis rescheduling might impact the growth and operational strategies of NuLeaf Naturals moving forward?
In what ways does High Tide Inc. HITI believe that its extensive experience in health-focused brands will contribute to the goals of the NCCC and improve patient outcomes through its products?
**MWN-AI FAQ is based on asking OpenAI questions about High Tide Inc. (NASDAQ: HITI).
NASDAQ: HITI
HITI Trading
0.82% G/L:
$2.455 Last:
134,077 Volume:
$2.45 Open:
